311 results on '"Strittmatter, F"'
Search Results
2. Die Rolle von Druck und Temperatur bei Ureterorenoskopie und perkutaner Nephrolitholapaxie: Druck- und Temperaturveränderungen im Rahmen der Steintherapie
3. Management von Harnleiterverletzungen
4. Wertigkeit der Bildgebung bei Tumoren des oberen Harntraktes
5. Die Striktur der vesikourethralen Anastomose nach radikaler Prostatektomie
6. Diagnostischer Workup bei der Harnröhrenstriktur
7. Urethrastriktur: Von der Diagnostik bis zur sinnvollen Therapie
8. Dual energy can accurately differentiate uric acid-containing urinary calculi from calcium stones
9. Therapie des Steinleidens
10. Pharmacological characterization of the β3-adrenoceptor agonists ZD7114, ZD2079 and BRL37344 in human prostate smooth muscle contraction
11. Inhibition of smooth muscle contraction in isolated human detrusor tissues by mirabegron requires concentrations out of therapeutic range, and is limited to neurogenic contractions
12. Inhibition of α1-adrenergic, non-adrenergic and neurogenic human prostate smooth muscle contraction by the isoflavone compounds genistein and puerarin
13. WNK463 and HTH01-015 simultaneously inhibit neurogenic and α1-blocker-resistant, non-adrenergic contractions of human prostate tissues, and growth-related functions of prostate stromal cells
14. Accurate diagnosis of prostate cancer via infrared spectroscopy of breath
15. Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864
16. Urinmarkersysteme zur Diagnostik des Urothelkarzinoms
17. Bildgebung zur Diagnostik der Urolithiasis einschließlich Dual-Energy-CT
18. Management des Uretersteins
19. Stellenwert der α1-Adrenozeptorblocker und 5α-Reduktaseinhibitoren: Monotherapie bei der Behandlung des benignen Prostatasyndroms
20. Ätiologie und Pathophysiologie der benignen Prostatahyperplasie
21. Operative Therapie des benignen Prostatasyndroms (BPS)
22. Medikamentöse Therapie des benignen Prostatasyndroms
23. Lymphknotenmetastasendiagnostik bei urologischen Tumoren
24. Mirabegron inhibits neurogenic and α1-adrenergic human prostate smooth muscle contractions, with similar pharmacologic patterns as α1-blockers
25. Diagnostik des Harnblasenkarzinoms
26. Verletzungen des Nierenbeckens und des Ureters: Diagnostik und Management
27. Einfluss der BCG-Instillationstherapie auf die diagnostische Aussagekraft der Urinzytologie bei der Detektion von high-grade Harnblasenkarzinomen
28. 1931 prepaid price list of home grown flower and garden plants for sale by Strittmatter Honey and Plant Co., Inc. /
29. 1926 prepaid price list of home grown flower and garden plants for sale by Strittmatter Honey and Plant Co., Inc. /
30. Inhibition of adrenergic human prostate smooth muscle contraction by the inhibitors of c-Jun N-terminal kinase, SP600125 and BI-78D3
31. GENITAL BLOODFLOW AND BLADDER FUNCTION IN A FEMALE RAT MODEL FOR NERVE-SPARING HYSTERECTOMY: #8
32. Einfluss der BCG-Instillationstherapie auf die diagnostische Aussagekraft der Urinzytologie bei der Detektion von high-grade Harnblasenkarzinomen
33. Inhibition of prostate smooth muscle contraction by NAV2729: Evidence for a role of ADP ribosylation factor 6 (ARF6) for prostate smooth muscle contraction
34. Ghrelin-mediated promotion of prostate growth and prostate smooth muscle contraction: Evidence from functional, in vivo, and genomic approaches
35. Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
36. A0597 - Inhibition of α1-adrenergic, non-adrenergic and neurogenic human prostate smooth muscle contraction by the isoflavone compounds genistein and puerarin
37. A0599 - WNK463 and HTH01-015 simultaneously inhibit neurogenic and α1-blocker-resistant, non-adrenergic contractions of human prostate tissues, and growth-related functions of prostate stromal cells
38. A0598 - Pharmacological characterization of the β3-adrenoceptor agonists ZD7114, ZD2079 and BRL37344 in human prostate smooth muscle contraction
39. A0438 - Inhibition of smooth muscle contraction in isolated human detrusor tissues by mirabegron requires concentrations out of therapeutic range, and is limited to neurogenic contractions
40. Der Einfluss von pre-stenting auf Steinfreiheitsrate und perioperative Komplikationen im Rahmen der endourologischen Steintherapie
41. Accurate diagnosis of prostate cancer via infrared spectroscopy of breath
42. P0031 - Mirabegron inhibits neurogenic and α1-adrenergic human prostate smooth muscle contractions, with similar pharmacologic patterns as α1-blockers
43. New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention
44. Inhibition of prostate smooth muscle contraction by inhibitors of polo-like kinases (PLK): A new role for PLK1 in smooth muscle contraction?
45. Novel evidence for a role of the ghrelin system in the hyperplastic prostate: Connecting the metabolic syndrome and lower urinary tract symptoms suggestive of BPH?
46. Erratum zu: Medikamentöse Therapie des benignen Prostatasyndroms
47. Funktionelle Kurzzeitergebnisse der Harnleiterrekonstruktion mit Mundschleimhaut bei langstreckigen proximalen Strikturen
48. The fatty acid amide hydrolase inhibitor oleoyl ethyl amide counteracts bladder overactivity in female rats
49. Urethrastriktur
50. Inhibition of prostate smooth muscle contraction by the LIM kinase inhibitor, SR-7826: A new anticontractile strategy and implications for a role of LIM kinases in the control of prostate smooth muscle tone
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.